Evasion of apoptosis by tumor cells is a hallmark of cancer [5] and defects in cancer cell apoptosis have been described at any point along the apoptotic pathways, including impaired receptor signaling, disrupted balance of anti- and pro-apoptotic Bcl-2 family proteins, reduced expression of caspases and increased expression of regulatory proteins (e.g., IAPs). Here, BCL2 is linked to cancer.